Please login to the form below

Not currently logged in
Email:
Password:

GSK wins sports contract

GSK has signed a contract with the World Anti-Doping Agency to help detect drugs that have performance-enhancing potential in sport

GlaxoSmithKline (GSK) has signed a deal with the World Anti-Doping Agency (WADA) to help scientists develop early detection methods for drugs that have performance-enhancing potential in sport.

GSK will supply WADA with confidential information about medicines in early stage development that may be abused by athletes once they are licensed. The deal covers all new drugs being developed by GSK.

The company said: "Scientists will look for any similarity to the pharmacological characteristics of existing performance-enhancing substances and assess how they work in the human body, this would include stimulatory effects or improved physical endurance."

New drugs found to have performance-enhancing potential will be highlighted to WADA and confidential scientific data relating to them would be transferred by GSK so anti-doping experts can begin work on detection methods.

4th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics